Menu
Not yet recruiting NCT07214194

Vagus Nerve Stimulation to Enhance Memory in Aging

No phase Interventional Alzheimer Disease Aging

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS).
Who it may be relevant to
Registry conditions: Alzheimer Disease, Aging. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is to determine whether non-invasive vagus nerve stimulation enhances memory formation in cognitively healthy older adults and whether the effects of stimulation depend on gut and brain health.

Interventions

  • Device Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
    Non-invasive vagus nerve stimulation will be delivered with a well-validated device. taVNS delivers stimulation on the left ear, with the placement of the stimulating electrode differing between the active and sham conditions. Stimulation will occur during each learning trial (total of 30 trials per phase).

Primary outcome measures

  • Change in Recognition Memory (d-prime) [Time frame: post-active vs post-sham stimulation; up to 2 hours of task]

Eligibility criteria

Inclusion criteria

  • Ages 18-30 years or 65-80 years
  • Normal or corrected-to-normal vision (visual acuity)
  • Fluent in English

Exclusion criteria

  • Pregnant
  • Symptoms of memory loss
  • History of a neurological, psychiatric, or medical condition that could affect cognition or preclude MRI or pupillometry
  • Use of medications known to alter cognition
  • For older adults, neuropsychological performance that falls outside 1.5 standard deviations of age-adjusted norms and no self-reported memory or attention complaints

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Basic science

Study locations

United States · 1 center
  • Stanford University — Stanford

Identifiers

NCT: NCT07214194 · VNS102025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗